search
Back to results

The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis

Primary Purpose

Multiple Sclerosis

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Forced Aerobic Exercise (FE)
Voluntary Aerobic Exercise (VE)
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis focused on measuring aerobic exercise, gait

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Confirmed diagnosis of RRMS with Expanded Disability Status Scale (EDSS) score between 1.5 and 6.5,
  2. 18-75 years of age,
  3. Deemed minimal risk for cardiovascular event using American College of Sports Medicine Exercise Pre-participation Criteria

Exclusion Criteria:

  1. hospitalization for myocardial infarction, heart failure or heart surgery within 3 months,
  2. serious cardiac arrhythmia,
  3. hypertrophic cardiomyopathy,
  4. severe aortic stenosis,
  5. pulmonary embolus,
  6. significant contractures,
  7. dysphagia resulting in inability to sufficiently hydrate, and
  8. other contraindication to exercise.

Sites / Locations

  • Cleveland Clinic Main Campus
  • Cleveland Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Forced Aerobic Exercise (FE)

Voluntary Aerobic Exercise (VE)

Arm Description

The FE group (N=10) will complete 45 minutes of FE on the custom-engineered cycle designed to augment pedaling rate to greater than 70 revolutions per minute (RPM's). The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer at their self-selected cadence without assistance.

The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer for 45 minutes at their self-selected cadence without assistance.

Outcomes

Primary Outcome Measures

Exercise variables
Exercise cadence, power, and aerobic intensity achieved during the 35-minute main exercise set
Biomechanical Gait Assessment
Spatio-temporal and kinematic parameters of gait will be obtained using 3-D motion capture and an instrumented walkway. The following biomechanical outcomes will be calculated: 1) spatio-temporal: velocity; cadence, step length, percentage of gait cycle spent in swing and stance phase, single and double limb support time and percentage; 2) Kinematic: hip and knee flexion and extension; ankle dorsi- and plantar-flexion; pelvic obliquity, rotation and tilt.
Instrumented Timed Up and Go (TUG)
The TUG will be administered while participants wear an iPad to collect biomechanical data during the clinical test
Six Minute Walk Test
The distance walked over 6 minutes is measured on an oval walking track
PROMIS-29
self-reported measure of quality of life
Multiple Sclerosis Performance Test
Assessment examining cognitive and visual function for persons with MS

Secondary Outcome Measures

Modified Fatigue Impact Scale
self-reported measure of fatigue
To investigate the role of Klotho in promoting neuroprotection.
Laboratory Assessment: Blood draws will be conducted at 4 different points in time to determine the acute and long-term change in serum Klotho; at week one session one, pre- and post-exercise, and at the last session12-week exercise intervention, pre- and post-exercise.

Full Information

First Posted
May 10, 2021
Last Updated
September 28, 2022
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT04906057
Brief Title
The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis
Official Title
The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 6, 2021 (Actual)
Primary Completion Date
December 1, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This project will investigate the feasibility and initial efficacy of two aerobic exercise training approaches, forced and voluntary, to improve motor function in persons with multiple sclerosis (MS). We hypothesize that intensive aerobic exercise training elicits a neurorepairative and neurorestorative response on the central nervous system, which may improve motor function as it relates to gait and mobility. Should aerobic cycling, forced or voluntary, improve gait and functional mobility in persons with MS, it would serve as a new model to restoring function, rather than current models that focus on compensation.
Detailed Description
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system characterized by progressive loss of motor function, cognitive function, in addition to symptoms of fatigue and depression. These motor and non-motor symptoms negatively affect the individuals' walking ability, functional mobility, quality of life, ability to maintain gainful employment, and social engagement. Identifying rehabilitation approaches that may delay disease progression or restore lost neurologic function would have considerable impact in the field. The goal of this project is to investigate the feasibility and initial efficacy of forced or voluntary aerobic exercise training to improve gait, functional mobility, fatigue and quality of life in persons with multiple sclerosis (PwMS). Current rehabilitative approaches for PwMS focus on training compensatory strategies rather than restoring neurological function. Substantial evidence indicates that aerobic exercise (AE) training has the potential to enhance neurological function by restoring and repairing damaged cells, leading to improvements in gait, balance, and cognitive function in PwMS. Despite evidence of the potential disease-modifying properties of AE, numerous physical, behavioral, and logistical barriers prevent PwMS from achieving and maintaining AE of sufficient intensity and duration to capitalize on the neurophysiologic benefits of training. Forced exercise (FE) is a novel approach to AE training that has been successfully applied to individuals with Parkinson's disease and stroke, in which the voluntary efforts of the individual are augmented, allowing for disease-altering effects of intensive exercise training. During FE, pedaling cadence on a stationary cycle is augmented by a motor to assist, but not replace, the voluntary efforts of the individual. It is hypothesized that PwMS cannot sustain high rates of voluntary exercise necessary to elicit neural repair; therefore, FE is necessary to overcome physical, behavioral and logistical barriers to enhance neuroplasticity to improve gait, QOL, and the ability to participate in life activities. Positive results from our FE trials in Parkinson's disease and stroke have guided us in designing the scientific methodology for the proposed trial in PwMS. Twenty adults with relapsing-remitting MS and mild to moderate gait impairment will be randomized to undergo 1) FE or 2) voluntary aerobic exercise (VE). Both groups will attend 2X/week for 12 weeks. Exercise variables will be collected for each session as a measure of feasibility to determine how PwMS respond to each exercise approach. Clinical, biomechanical, and self-reported outcomes will be gathered prior to, after, and 4-weeks after the intervention to determine the effects of both modes of exercise on spatiotemporal and kinematic characteristics of gait, functional mobility, balance, fatigue, physical activity levels, and quality of life. Should our findings confirm our hypothesis that intensive exercise training can have disease-altering effects, a new direction for MS rehabilitation approaches would ensue, empowering PwMS to take control of their disease to improve function and reduce disability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
aerobic exercise, gait

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
rater-blind, prospective randomized trial
Masking
Outcomes Assessor
Masking Description
Group allocation will be concealed to the individual obtaining all outcomes of interest
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Forced Aerobic Exercise (FE)
Arm Type
Experimental
Arm Description
The FE group (N=10) will complete 45 minutes of FE on the custom-engineered cycle designed to augment pedaling rate to greater than 70 revolutions per minute (RPM's). The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer at their self-selected cadence without assistance.
Arm Title
Voluntary Aerobic Exercise (VE)
Arm Type
Active Comparator
Arm Description
The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer for 45 minutes at their self-selected cadence without assistance.
Intervention Type
Behavioral
Intervention Name(s)
Forced Aerobic Exercise (FE)
Intervention Description
High-rate aerobic exercise on a semi-recumbent custom-designed stationary cycle ergometer
Intervention Type
Behavioral
Intervention Name(s)
Voluntary Aerobic Exercise (VE)
Intervention Description
Voluntary-rate aerobic exercise on a semi-recumbent stationary cycle ergometer
Primary Outcome Measure Information:
Title
Exercise variables
Description
Exercise cadence, power, and aerobic intensity achieved during the 35-minute main exercise set
Time Frame
collected during each exercise session (twice per week for 12 weeks)
Title
Biomechanical Gait Assessment
Description
Spatio-temporal and kinematic parameters of gait will be obtained using 3-D motion capture and an instrumented walkway. The following biomechanical outcomes will be calculated: 1) spatio-temporal: velocity; cadence, step length, percentage of gait cycle spent in swing and stance phase, single and double limb support time and percentage; 2) Kinematic: hip and knee flexion and extension; ankle dorsi- and plantar-flexion; pelvic obliquity, rotation and tilt.
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Title
Instrumented Timed Up and Go (TUG)
Description
The TUG will be administered while participants wear an iPad to collect biomechanical data during the clinical test
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Title
Six Minute Walk Test
Description
The distance walked over 6 minutes is measured on an oval walking track
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Title
PROMIS-29
Description
self-reported measure of quality of life
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Title
Multiple Sclerosis Performance Test
Description
Assessment examining cognitive and visual function for persons with MS
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Secondary Outcome Measure Information:
Title
Modified Fatigue Impact Scale
Description
self-reported measure of fatigue
Time Frame
Week 0 (baseline), Week 13 (post exercise sessions)
Title
To investigate the role of Klotho in promoting neuroprotection.
Description
Laboratory Assessment: Blood draws will be conducted at 4 different points in time to determine the acute and long-term change in serum Klotho; at week one session one, pre- and post-exercise, and at the last session12-week exercise intervention, pre- and post-exercise.
Time Frame
Week 1 (exercise session 1), Week 12 (exercise session 24)

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
Participants identifying as male or female are eligible
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Confirmed diagnosis of RRMS with Expanded Disability Status Scale (EDSS) score between 1.5 and 6.5, 18-75 years of age, Deemed minimal risk for cardiovascular event using American College of Sports Medicine Exercise Pre-participation Criteria Exclusion Criteria: hospitalization for myocardial infarction, heart failure or heart surgery within 3 months, serious cardiac arrhythmia, hypertrophic cardiomyopathy, severe aortic stenosis, pulmonary embolus, significant contractures, dysphagia resulting in inability to sufficiently hydrate, and other contraindication to exercise.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susan M Linder, DPT
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic Main Campus
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis

We'll reach out to this number within 24 hrs